Public Employees Retirement System of Ohio Has $27.60 Million Position in CVS Health Co. (NYSE:CVS)

Public Employees Retirement System of Ohio cut its position in CVS Health Co. (NYSE:CVS - Free Report) by 3.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 614,924 shares of the pharmacy operator's stock after selling 20,872 shares during the quarter. Public Employees Retirement System of Ohio's holdings in CVS Health were worth $27,604,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in CVS. Vega Investment Solutions bought a new stake in shares of CVS Health during the 4th quarter worth $359,000. Vise Technologies Inc. grew its stake in CVS Health by 23.4% during the fourth quarter. Vise Technologies Inc. now owns 11,703 shares of the pharmacy operator's stock worth $525,000 after purchasing an additional 2,219 shares during the period. DCM Advisors LLC grew its stake in CVS Health by 15.5% during the fourth quarter. DCM Advisors LLC now owns 81,530 shares of the pharmacy operator's stock worth $3,435,000 after purchasing an additional 10,920 shares during the period. Orion Capital Management LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $54,000. Finally, McIlrath & Eck LLC grew its stake in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 174 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on CVS shares. Barclays lifted their price target on CVS Health from $73.00 to $82.00 and gave the stock an "overweight" rating in a report on Friday, May 2nd. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Argus set a $77.00 price objective on CVS Health in a report on Tuesday, February 18th. Truist Financial boosted their target price on CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Finally, Wolfe Research increased their price objective on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $74.94.

CVS Health Trading Up 0.4%

Shares of CVS traded up $0.23 during midday trading on Thursday, hitting $62.68. 4,510,724 shares of the stock were exchanged, compared to its average volume of 11,266,702. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $72.51. The stock has a fifty day simple moving average of $65.76 and a 200 day simple moving average of $59.48. The firm has a market cap of $79.29 billion, a P/E ratio of 17.11, a P/E/G ratio of 0.98 and a beta of 0.60. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the firm earned $1.31 earnings per share. On average, research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.24%. CVS Health's payout ratio is 63.48%.

Insider Activity at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares in the company, valued at approximately $556,941.90. This trade represents a 47.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.22% of the stock is owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.